Hims & Hers Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 144.84 million compared to USD 74.17 million a year ago. Net loss was USD 18.84 million compared to USD 15.94 million a year ago.
For the nine months, sales was USD 359.71 million compared to USD 187.18 million a year ago. Net loss was USD 54.77 million compared to USD 76.5 million a year ago.